Literature DB >> 3231902

Bronchoalveolar lavage in chronic eosinophilic pneumonia. Analysis of six cases in comparison with other interstitial lung diseases.

A Pesci1, G Bertorelli, P Manganelli, P A Mori, F Strinati, E Marangio, D Olivieri.   

Abstract

We describe 6 patients with chronic eosinophilic pneumonia (CEP) investigated clinically and by bronchoalveolar lavage (BAL). The BAL findings of these 6 patients were compared with those of 293 patients with other interstitial lung diseases (ILD): 184 with sarcoidosis, 63 with hypersensitivity pneumonitis, 46 with idiopathic pulmonary fibrosis (IPF). In patients with CEP, BAL analysis was characterized by a markedly increased number of eosinophils (mean +/- 1 SD: 54.2 +/- 26.4 of effector cells; in control subjects, eosinophils were less than 1% of effector cells). In patients with other ILD, BAL fluid analysis showed a significant increase in the percentage of eosinophils only in the group of IPF, but in IPF the increased number of eosinophils is linked with a significant increase in the percentage of neutrophils. These findings indicate that besides the classic patterns of lymphocytosis or polymorphonuclear leukocytosis, a predominantly eosinophilic pattern may also be present in the BAL fluid. Moreover, BAL may contribute to understanding the pathogenesis of lung tissue damage in CEP.

Entities:  

Mesh:

Year:  1988        PMID: 3231902     DOI: 10.1159/000195475

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  2 in total

1.  Eosinophilic alveolitis in immunologic interstitial lung disorders.

Authors:  D Olivieri; A Pesci; G Bertorelli
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Segregation of eosinophil proteins in alveolar macrophage compartments in chronic eosinophilic pneumonia.

Authors:  A Janin; G Torpier; P Courtin; M Capron; L Prin; A B Tonnel; P Y Hatron; B Gosselin
Journal:  Thorax       Date:  1993-01       Impact factor: 9.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.